Doctolib

Healthtech · AI Infrastructure

Partnership

Nvidia takes minority stake in French health platform Doctolib

The deal lets the appointment-booking giant build proprietary AI models instead of leaning on US providers like OpenAI or Anthropic.

• Nvidia agreed to take an undisclosed minority stake of under 5% in Doctolib, announced by CEO Jensen Huang at a Paris press conference on October 13, 2026.
• Doctolib runs France's leading platform for booking medical appointments and storing health records, serving about 50 million users.
• Nvidia joins as a shareholder with no board seat; Doctolib says the capital will fund hiring and its own AI models for patient and clinician assistants, built on Nvidia chips and compute rather than outside providers like OpenAI or Anthropic.
• The Doctolib stake is one of four French startup investments Nvidia unveiled the same day (alongside Genesis AI, Pigment and Entalpic), part of at least $8 billion Nvidia poured into Europe in 2025, plus a separate $250 million UK compute pledge over five years.
• Doctolib was last valued at €3.6 billion (about $3.9 billion) in a spring 2026 funding round, and in August launched a research program using user data that drew criticism from the Ligue des droits de l'Homme over privacy risks.
• The deal shows Nvidia embedding itself as an infrastructure and equity partner across Europe's AI ecosystem, giving a sensitive health-data company a stake in chip supply while letting it argue it retains sovereign control of its models.